Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
1637
mi
from 02139
Lake Jackson, TX
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
2281
mi
from 02139
Mesa, AZ
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
1410
mi
from 02139
Newton, KS
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
469
mi
from 02139
Norfolk, VA
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
1249
mi
from 02139
North Miami, FL
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
479
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
1533
mi
from 02139
Plano, TX
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
2481
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
2097
mi
from 02139
South Jordan, UT
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
1051
mi
from 02139
St. Peter's, MO
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Parkinsons Disease and Movement Disorders Center
1216
mi
from 02139
Boca Raton, FL
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan State University - Dept. of Neurology
680
mi
from 02139
East Lansing, MI
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Bendheim Parkinson's and Movement Disorder Center (Mount Sinai Medical Center)
227
mi
from 02139
New York, NY
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Jefferson University Hospital Philadelphia
269
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Hospital
623
mi
from 02139
West Bloomfield, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Other Clinical Trial
Biomarkers in Infection
Status: Enrolling, Phase
Updated: 12/31/1969
St. Vincent's Hospital
36
mi
from 02139
Worcester, MA
Click here to add this to my saved trials
Pneumonia, Bacterial Clinical Trial
A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Status: Enrolling, Phase I
Updated: 12/7/2015
Clinical Research Facility
1490
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Anne Arundel Oncology Center
366
mi
from 02139
Annapolis, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Health & Services/Oregon Clinic
2527
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Atlantic Health
205
mi
from 02139
Morristown, NJ
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1076
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2377
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
Hemophilia Clinical Trial
ATHN 2: Factor Switching Study
Status: Enrolling, Phase
Updated: 12/31/1969
Yale Hemophilia Treatment Center
119
mi
from 02139
New Haven, CT
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Coastal Health Care
113
mi
from 02139
Freeport, ME
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Bronson Neurobehavioral Health
755
mi
from 02139
Paw Paw, MI
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1763
mi
from 02139
Denver, CO
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2586
mi
from 02139
Glendale, AZ
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2550
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
260
mi
from 02139
Syracuse, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Lurie Children's
847
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Oregon Health & Science
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Children's National
390
mi
from 02139
Washington DC,
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Alberta Children's Hospital
2092
mi
from 02139
Calgary,
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of the King's Daughters (CHKD)
469
mi
from 02139
Norfolk, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
164
mi
from 02139
Harrison, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 4/3/2018
St. Vincent Heart Clinic
1255
mi
from 02139
Little Rock, AR
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati Medical Center/ Investigational Pharmacy
732
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Health Ridgeway Hospital
732
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke University Hospital, Investigational Drug Service
606
mi
from 02139
Durham, NC
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UT Physicians Comprehensive Sickle Cell Center Houston
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Mississippi Medical Center-Outpatient Clinical Research Unit
1251
mi
from 02139
Jackson, MS
Click here to add this to my saved trials
Delayed Function of Renal Transplant Clinical Trial
Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
Status: Enrolling, Phase II, III
Updated: 6/14/2016
UIC University of Illinois at Chicago
849
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1584
mi
from 02139
Baytown, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
473
mi
from 02139
Chesapeake, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1100
mi
from 02139
Dothan, AL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
179
mi
from 02139
Flushing, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1128
mi
from 02139
Inverness, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1333
mi
from 02139
Monroe, LA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
469
mi
from 02139
Norfolk, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
151
mi
from 02139
Poughkeepsie, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1034
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1304
mi
from 02139
Topeka, KS
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
859
mi
from 02139
Wauwatosa, WI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1767
mi
from 02139
Wheat Ridge, CO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
1110
mi
from 02139
Winter Park, FL
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
267
mi
from 02139
East Norriton, PA
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
256
mi
from 02139
East Syracuse, NY
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
1140
mi
from 02139
Jonesboro, AR
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
Augusta University Health
852
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Homestead Research Institute
1282
mi
from 02139
Homestead, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Houston Clinical Research Associates
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
New Jersey Medical School, Rutgers University
195
mi
from 02139
Newark, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Tech Carilion School of Medicine Pediatric Gastroenterology
585
mi
from 02139
Roanoke, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Frontier Clinical Research, LLC
466
mi
from 02139
Scottdale, PA
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Study to Evaluate the Safety and Tolerability of ETC-1922159 in Advanced Solid Tumours
Status: Enrolling, Phase I
Updated: 1/5/2018
National University Hospital
9399
mi
from 02139
Singapore,
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Royal Adelaide Hospital
10763
mi
from 02139
Adelaide,
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Clinical Research, LLC
883
mi
from 02139
Athens, GA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Norhwestern Memorial Hospital
845
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Center for Digestive Health
527
mi
from 02139
Mentor, OH
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
New York University (NYU) Langone Medical Center
186
mi
from 02139
New York, NY
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
Status: Enrolling, Phase I
Updated: 4/21/2016
Clinical Research Facility
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
The Beatson West of Scotland Cancer Centre
3029
mi
from 02139
Glasgow,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System (GHS) Cancer Institute
802
mi
from 02139
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwell Health
174
mi
from 02139
Lake Success, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Albert Einstein Medical Center, Cancer Center
264
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hawaii Oncology Inc-Pali Momi
5078
mi
from 02139
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Mills-Peninsula Medical Center
2693
mi
from 02139
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Joseph Mercy Canton
632
mi
from 02139
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Caro Cancer Center
626
mi
from 02139
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Beaumont Hospital-Dearborn
619
mi
from 02139
Dearborn, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Palo Alto Medical Foundation-Fremont
2674
mi
from 02139
Fremont, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Aurora Health Care Germantown Health Center
862
mi
from 02139
Germantown, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Adams Clinic
1119
mi
from 02139
Hibbing, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hawaii Cancer Care Inc-POB II
5078
mi
from 02139
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hope Cancer Clinic
627
mi
from 02139
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Aurora Bay Area Medical Group-Marinette
844
mi
from 02139
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Chancellor Center for Oncology
912
mi
from 02139
Newburgh, IN
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Alphonsus Medical Center-Ontario
2283
mi
from 02139
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Great Lakes Cancer Management Specialists-Rochester Hills
602
mi
from 02139
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Siteman Cancer Center at Christian Hospital
1032
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Marshfield Clinic Stevens Point Center
935
mi
from 02139
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Macomb Hematology Oncology PC
606
mi
from 02139
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Bhadresh Nayak MD PC-Warren
605
mi
from 02139
Warren, MI
Click here to add this to my saved trials